Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material:: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas

被引:86
作者
Hostein, I
Pelmus, M
Aurias, A
Pedeutour, F
Mathoulln-Pélissier, S
Coindre, JM
机构
[1] Inst Bergonie, Dept Pathol, F-33076 Bordeaux, France
[2] Inst Curie, Res Sect, INSERM, U509, Paris, France
[3] Archet Univ Hosp, Genet Lab, Nice, France
[4] Inst Bergonie, Dept Biostat, Bordeaux, France
关键词
atypical lipomatous tumour; well-differentiated liposarcoma; dedifferentiated liposarcoma; MDM2; CDK4; real-time PCR; paraffin wax-embedded tissues; quantification;
D O I
10.1002/path.1495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Atypical lipomatous tumours/well-differentiated liposarcomas and dedifferentiated liposarcomas are characterized by 12q13-15 region amplification. In contrast, this molecular event has not been reported in benign lipomas. Within the 12q13-15 chromosomal region, the MDM2, SAS, HMGA2, and CDK4 genes are the most frequent targets of amplification. A series of lipomas (36 cases) and liposarcomas (48 cases) was analysed for MDM2 and CDK4 gene amplification by real-time PCR. MDM2 and CDK4 gene amplification was detected in 2.8% and 5.6% of lipomas and 98.2% and 82.4% of liposarcomas, respectively. Moreover, co-amplification of the two genes as well as a higher-level amplification was observed more frequently in dedifferentiated liposarcomas than in atypical lipomatous tumours/well-differentiated liposarcomas. Real-time PCR proved to be a fast and reliable method to characterize lipomas and liposarcomas by quantification of MDM2 and CDK4 gene amplification. It is applicable to paraffin wax-embedded tissues and could be useful when histological diagnosis is difficult. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 29 条
[1]  
Arbiser ZK, 2001, AM J CLIN PATHOL, V116, P473
[2]  
Bièche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO
[3]  
2-9
[4]   Distinction between lipoma and liposarcoma by MDM2 alterations:: A case report of simultaneously occurring tumors and review of the literature [J].
Boltze, C ;
Schneider-Stock, R ;
Jäger, V ;
Roessner, A .
PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (08) :563-568
[5]   A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas [J].
Chibon, F ;
Mariani, O ;
Derré, J ;
Malinge, S ;
Coindre, JM ;
Guillou, L ;
Lagacé, W ;
Aurias, A .
CANCER GENETICS AND CYTOGENETICS, 2002, 139 (01) :24-29
[6]  
Dei Tos A P, 2000, Ann Diagn Pathol, V4, P252, DOI 10.1053/adpa.2000.8133
[7]  
FLETCHER CDM, 2000, WHO CLASSIFICATION T
[8]  
Fritz B, 2002, CANCER RES, V62, P2993
[9]   Comparative genomic hybridization study of paraffin-embedded dedifferentiated liposarcoma fixed with Holland Bouin's fluid [J].
Hostein, I ;
Coindre, JM ;
Derré, J ;
Mariani, O ;
Chibon, F ;
Aurias, A .
DIAGNOSTIC MOLECULAR PATHOLOGY, 2003, 12 (03) :166-173
[10]   Atypical lipomatous tumor in a 14-year-old patient: distinction from lipoblastoma using FISH analysis [J].
Kuhnen, C ;
Mentzel, T ;
Fisseler-Eckhoff, A ;
Debiec-Rychter, M ;
Sciot, R .
VIRCHOWS ARCHIV, 2002, 441 (03) :299-302